COM:HIKMA
Hikma Pharmaceuticals
- Stock
Last Close
1,950.00
25/11 09:22
Market Cap
40.38M
Beta: -
Volume Today
39.31K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 212M - | 278M 31.13% | 252M 9.35% | 155M 38.49% | -843M 643.87% | 282M 133.45% | 486M 72.34% | 431M 11.32% | 421M 2.32% | 188M 55.34% | 281M 49.47% | |
depreciation and amortization | 62M - | 62M 0% | 66M 6.45% | 105M 59.09% | 125M 19.05% | 99M 20.80% | 107M 8.08% | 125M 16.82% | 169M 35.20% | 182M 7.69% | 259M 42.31% | |
deferred income tax | 105M - | 6M 94.29% | 59M 883.33% | 138M 133.90% | -43M 131.16% | 71M 265.12% | -20M 128.17% | 200M 1,100% | 99M 50.50% | 76M 23.23% | -125M 264.47% | |
stock based compensation | 7M - | 8M 14.29% | 15M 87.50% | 22M 46.67% | 22M 0% | 21M 4.55% | 24M 14.29% | 27M 12.50% | 29M 7.41% | 22M 24.14% | 25M 13.64% | |
change in working capital | -112M - | -14M 87.50% | -74M 428.57% | -160M 116.22% | 21M 113.13% | -92M 538.10% | -4M 95.65% | -227M 5,575% | -128M 43.61% | -98M 23.44% | 80M 181.63% | |
accounts receivables | -110M - | -16M 85.45% | -78M 387.50% | -128M 64.10% | 52M 140.63% | -41M 178.85% | 21M 151.22% | -47M 323.81% | -166M 253.19% | 4M 102.41% | ||
inventory | -2M - | 2M 200% | 4M 100% | -32M 900% | -31M 3.13% | -51M 64.52% | -25M 50.98% | -180M 620% | 38M 121.11% | -102M 368.42% | -115M 12.75% | |
accounts payables | ||||||||||||
other working capital | 195M - | |||||||||||
other non cash items | 168M - | 91M 45.83% | 107M 17.58% | 171M 59.81% | 1.12B 553.80% | 49M 95.62% | -121M 346.94% | -92M 23.97% | 48M 152.17% | 160M 233.33% | 88M 45% | |
net cash provided by operating activities | 337M - | 425M 26.11% | 366M 13.88% | 293M 19.95% | 443M 51.19% | 430M 2.93% | 472M 9.77% | 464M 1.69% | 638M 37.50% | 530M 16.93% | 608M 14.72% | |
investments in property plant and equipment | -59M - | -91M 54.24% | -82M 9.89% | -122M 48.78% | -107M 12.30% | -107M 0% | -119M 11.21% | -172M 44.54% | -145M 15.70% | -138M 4.83% | -204M 47.83% | |
acquisitions net | -21M - | -225M 971.43% | -515M - | 5M 100.97% | 27M 440.00% | 19M 29.63% | -60M 415.79% | -17M 71.67% | -380M 2,135.29% | -105M 72.37% | ||
purchases of investments | -22M - | -5M 77.27% | -21M 320% | -17M 19.05% | -10M 41.18% | -4M 60% | -6M 50% | -5M 16.67% | -3M 40% | -15M 400% | -27M 80% | |
sales maturities of investments | 43M - | 230M 434.88% | 532M - | 5M 99.06% | 4M 20% | 14M 250% | 2M 85.71% | 6M 200% | 395M 6,483.33% | 1M 99.75% | ||
other investing activites | -13M - | -21M 61.54% | -59M 180.95% | -41M 30.51% | -39M 4.88% | -16M 58.97% | -59M 268.75% | -48M 18.64% | -79M 64.58% | -469M 493.67% | 2M 100.43% | |
net cash used for investing activites | -115M - | -342M 197.39% | -162M 52.63% | -695M 329.01% | -151M 78.27% | -96M 36.42% | -151M 57.29% | -283M 87.42% | -238M 15.90% | -607M 155.04% | -333M 45.14% | |
debt repayment | -117M - | -121M 3.42% | -91M 24.79% | -326M 258.24% | -401M 23.01% | -224M 44.14% | -23M 89.73% | -1.39B 5,926.09% | -76M 94.52% | -971M 1,177.63% | -1.31B 34.71% | |
common stock issued | 2M - | 1M - | 1.76B - | 1.27B - | ||||||||
common stock repurchased | -4M - | 90M - | -375M - | -300M - | ||||||||
dividends paid | -33M - | -39M 18.18% | -52M 33.33% | -77M 48.08% | -79M 2.60% | -84M 6.33% | -97M 15.48% | -109M 12.37% | -120M 10.09% | -125M 4.17% | -137M 9.60% | |
other financing activites | -77M - | 190M 346.75% | 219M 15.26% | 422M 92.69% | 260M 38.39% | 30M 88.46% | -35M 216.67% | -189M 440.00% | -91M 51.85% | 67M 173.63% | 1.11B 1,553.73% | |
net cash used provided by financing activities | -229M - | 30M 113.10% | 77M 156.67% | 19M 75.32% | -220M 1,257.89% | -278M 26.36% | -155M 44.24% | -298M 92.26% | -287M 3.69% | -58M 79.79% | -337M 481.03% | |
effect of forex changes on cash | -2M - | -1M 50% | -8M 700% | -15M 87.50% | -7M - | -2M - | -10M 400% | -21M 110.00% | -3M 85.71% | |||
net change in cash | -9M - | 112M 1,344.44% | 273M 143.75% | -398M 245.79% | 72M 118.09% | 49M 31.94% | 166M 238.78% | -119M 171.69% | 103M 186.55% | -156M 251.46% | -65M 58.33% | |
cash at beginning of period | 177M - | 168M 5.08% | 280M 66.67% | 553M 97.50% | 155M 71.97% | 227M 46.45% | 276M 21.59% | 442M 60.14% | 323M 26.92% | 426M 31.89% | 270M 36.62% | |
cash at end of period | 168M - | 280M 66.67% | 553M 97.50% | 155M 71.97% | 227M 46.45% | 276M 21.59% | 442M 60.14% | 323M 26.92% | 426M 31.89% | 270M 36.62% | 205M 24.07% | |
operating cash flow | 337M - | 425M 26.11% | 366M 13.88% | 293M 19.95% | 443M 51.19% | 430M 2.93% | 472M 9.77% | 464M 1.69% | 638M 37.50% | 530M 16.93% | 608M 14.72% | |
capital expenditure | -59M - | -91M 54.24% | -82M 9.89% | -122M 48.78% | -107M 12.30% | -107M 0% | -119M 11.21% | -172M 44.54% | -145M 15.70% | -138M 4.83% | -204M 47.83% | |
free cash flow | 278M - | 334M 20.14% | 284M 14.97% | 171M 39.79% | 336M 96.49% | 323M 3.87% | 353M 9.29% | 292M 17.28% | 493M 68.84% | 392M 20.49% | 404M 3.06% |
All numbers in GBP (except ratios and percentages)